MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
PTPN7 |
IPI00081833 |
3.34 |
Evidence |
|
NR3C1 |
NR3C1, GRL: Glucocorticoid receptor |
DUSP6 |
DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 |
3.34 |
Evidence |
|
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
CDC42 |
IPI00016786 |
3.34 |
Evidence |
|
CETP |
CETP: Cholesteryl ester transfer protein precursor |
PLTP |
PLTP: Phospholipid transfer protein precursor |
3.34 |
Evidence |
|
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
C9orf88 |
IPI00647286 |
3.34 |
Evidence |
|
RXRA |
RXRA, NR2B1: Retinoic acid receptor RXR-alpha |
DUSP6 |
DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 |
3.34 |
Evidence |
|
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
ZAK |
MLTK, ZAK, HCCS4: Mitogen-activated protein kinase kinase kinase MLT |
3.34 |
Evidence |
|
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
HNRPK |
HNRPK, HNRNPK: Heterogeneous nuclear ribonucleoprotein K |
3.34 |
Evidence |
|
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
MAP2K5 |
IPI00185860 |
3.34 |
Evidence |
|
AMBP |
AMBP, HCP, ITIL: AMBP protein precursor [Contains: Alpha-1-microglobulin |
PLAU |
Plasminogen activator, urokinase |
3.34 |
Evidence |
|
NR4A2 |
NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 |
MINK1 |
MAP4K6, MINK1, MINK: Misshapen-like kinase 1 |
3.34 |
Evidence |
|
VIM |
VIM: Vimentin |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
3.34 |
Evidence |
|
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
AR |
AR, DHTR, NR3C4: Androgen receptor |
3.34 |
Evidence |
|
ZFX |
ZFX: Zinc finger X-chromosomal protein |
SEC13L1 |
IPI00375370 |
3.34 |
Evidence |
|
NCF4 |
IPI00297156 |
HSP90AA1 |
Hsp89-alpha-delta-N |
3.34 |
Evidence |
|
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
AR |
AR, DHTR, NR3C4: Androgen receptor |
3.34 |
Evidence |
|
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
3.34 |
Evidence |
|
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
PTMA |
IPI00015550 |
3.34 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
ZYX |
ZYX: Zyxin |
3.34 |
Evidence |
|
YWHAG |
YWHAG: 14-3-3 protein gamma |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
3.34 |
Evidence |
|
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
AR |
AR, DHTR, NR3C4: Androgen receptor |
3.34 |
Evidence |
|
NFATC2 |
NFATC2, NFAT1, NFATP: Nuclear factor of activated T-cells, cytoplasmic 2 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
3.34 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
PPP1R12C |
PPP1R12C, MBS85: Protein phosphatase 1 regulatory subunit 12C |
3.34 |
Evidence |
|
GRK1 |
GRK1, RHOK: Rhodopsin kinase precursor |
CAMKK1 |
IPI00166909 |
3.34 |
Evidence |
|
PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
ZYX |
ZYX: Zyxin |
3.34 |
Evidence |
|